Digital Microfluidics in Newborn Screening for Mucopolysaccharidoses: A Progress Report
Newborn screening (NBS) for mucopolysaccharidosis type I (MPS I, Hurler syndrome) is currently conducted in about two-fifths of the NBS programs in the United States and in a few other countries. Screening is performed by measurement of residual activity of the enzyme <i>alpha</i>-<sp...
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | English |
| Publicado: |
MDPI AG
2020-10-01
|
| Series: | International Journal of Neonatal Screening |
| Subjects: | |
| Acceso en liña: | https://www.mdpi.com/2409-515X/6/4/78 |